Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2016 Dec 12;44(6):969–978. doi: 10.1007/s00259-016-3583-2

Table 1.

Patient demographics and clinical characteristics

No. of patient (%)
Characteristic (n=56)
Age, median (range) 65 years (21-91 years)
Sex
 Male 49 (88)
 Female 7 (12)
Race/ethnicity
 Caucasian 36 (64)
 Latino 10 (18)
 African American 7 (13)
 Asian 3 (5)
ECOG performance status
 0-1 45 (80)
 2-3 9 (16)
 Unknown 2 (4)
Tumor differentiation
 Well 8 (14)
 Moderately 18 (32)
 Poorly 6 (11)
 Unknown 24 (43)
Hepatitis infection
 HBV 6 (11)
 HCV 20 (36)
 HBV and HCV 1 (1)
 None 29 (52)
Cirrhosis
 Yes 33 (59)
 No 23 (41)
Varices
 Yes 15 (27)
 No 41 (73)
Endovascular invasion
 Yes 30 (54)
 No 26 (46)
Child-Pugh score
 A 37 (66)
 B 17 (30)
 C 1 (2)
 Unknown 1 (2)
TNM stage
 I 6 (11)
 II 8 (14)
 III 18 (32)
 IV 24 (43)
CLIP score
 0 8 (14)
 1 8 (14)
 2 12 (21)
 3 14 (25)
 4 4 (8)
 5 3 (5)
 Unknown 7 (13)
BCLC stage
 0 1 (2)
 A 4 (7)
 B 6 (11)
 C 42 (75)
 D 3 (5)

BCLC, Barcelona-Clinic Liver Cancer; CLIP, Cancer of the Liver Italian Program; ECOG, Eastern Cooperative Oncology Group; HBV, hepatitis B virus; HCV, hepatitis C virus.